These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 34250088)

  • 21. LncRNA RUSC1-AS1 promotes osteosarcoma progression through regulating the miR-340-5p and PI3K/AKT pathway.
    Tong CJ; Deng QC; Ou DJ; Long X; Liu H; Huang K
    Aging (Albany NY); 2021 May; 13(16):20116-20130. PubMed ID: 34048366
    [TBL] [Abstract][Full Text] [Related]  

  • 22. LncRNA MALAT1 regulates trophoblast cells migration and invasion via miR-206/IGF-1 axis.
    Wu HY; Wang XH; Liu K; Zhang JL
    Cell Cycle; 2020 Jan; 19(1):39-52. PubMed ID: 31774373
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long non-coding RNA PGM5-AS1 promotes epithelial-mesenchymal transition, invasion and metastasis of osteosarcoma cells by impairing miR-140-5p-mediated FBN1 inhibition.
    Liu W; Liu P; Gao H; Wang X; Yan M
    Mol Oncol; 2020 Oct; 14(10):2660-2677. PubMed ID: 32412676
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNA-489 targets XIAP to inhibit the biological progression of ovarian cancer via regulating PI3K/Akt signaling pathway and epithelial-to-mesenchymal transition.
    Jiang HW; Li L; Jiang P; Wang YF
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4113-4122. PubMed ID: 32373947
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of lncRNAHCP5/microRNA-525-5p/PRC1 crosstalk in the malignant behaviors of ovarian cancer cells.
    Wang L; He M; Fu L; Jin Y
    Exp Cell Res; 2020 Sep; 394(1):112129. PubMed ID: 32511950
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The miRNA mir-582-3p suppresses ovarian cancer progression by targeting AKT/MTOR signaling
    Dai T; Liang J; Liu W; Zou Y; Niu F; Li M; Zhang H; Li C; Fan M; Cui G
    Bioengineered; 2021 Dec; 12(2):10771-10781. PubMed ID: 34793263
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LncRNA ADPGK-AS1 promotes pancreatic cancer progression through activating ZEB1-mediated epithelial-mesenchymal transition.
    Song S; Yu W; Lin S; Zhang M; Wang T; Guo S; Wang H
    Cancer Biol Ther; 2018 Jul; 19(7):573-583. PubMed ID: 29667486
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Downregulation of long noncoding RNA TUSC7 promoted cell growth, invasion and migration through sponging with miR-616-5p/GSK3β pathway in ovarian cancer.
    Zhu LM; Li N
    Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7253-7265. PubMed ID: 32706063
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA-129-5p suppresses proliferation, migration and invasion of retinoblastoma cells through PI3K/AKT signaling pathway by targeting PAX6.
    Liu Y; Liang G; Wang H; Liu Z
    Pathol Res Pract; 2019 Dec; 215(12):152641. PubMed ID: 31727502
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MiR-206 inhibits HGF-induced epithelial-mesenchymal transition and angiogenesis in non-small cell lung cancer via c-Met /PI3k/Akt/mTOR pathway.
    Chen QY; Jiao DM; Wu YQ; Chen J; Wang J; Tang XL; Mou H; Hu HZ; Song J; Yan J; Wu LJ; Chen J; Wang Z
    Oncotarget; 2016 Apr; 7(14):18247-61. PubMed ID: 26919096
    [TBL] [Abstract][Full Text] [Related]  

  • 31. miR-18a-5p derived from mesenchymal stem cells-extracellular vesicles inhibits ovarian cancer cell proliferation, migration, invasion, and chemotherapy resistance.
    Wang X; Jiang L; Liu Q
    J Transl Med; 2022 Jun; 20(1):258. PubMed ID: 35672774
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MiR-200b-5p inhibits tumor progression in salivary adenoid cystic carcinoma via targeting BTBD1.
    Tang Y; Zhu Q; Yang L; Meng Y; Zhang G; Zhou T; Wang C; Song X; Su YX; Ye J
    Cell Signal; 2023 Sep; 109():110748. PubMed ID: 37290676
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hsa_circ_0030586 promotes epithelial-mesenchymal transition in prostate cancer via PI3K-AKT signaling.
    Luo GC; Chen L; Fang J; Yan ZJ
    Bioengineered; 2021 Dec; 12(2):11089-11107. PubMed ID: 34852706
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MiR-198 inhibits proliferation, invasion and migration of ovarian cancer cells by regulating the PI3K/Akt signaling pathway.
    Xiao H; Zheng Y; Chen J; Shen H
    Acta Biochim Pol; 2021 Jun; 68(4):673-677. PubMed ID: 34181826
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA-708 targeting ZNF549 regulates colon adenocarcinoma development through PI3K/AKt pathway.
    Zhao Z; Qin X
    Sci Rep; 2020 Oct; 10(1):16729. PubMed ID: 33028966
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long non-coding RNA linc00673 regulated non-small cell lung cancer proliferation, migration, invasion and epithelial mesenchymal transition by sponging miR-150-5p.
    Lu W; Zhang H; Niu Y; Wu Y; Sun W; Li H; Kong J; Ding K; Shen HM; Wu H; Xia D; Wu Y
    Mol Cancer; 2017 Jul; 16(1):118. PubMed ID: 28697764
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA-133b inhibits proliferation and invasion of ovarian cancer cells through Akt and Erk1/2 inactivation by targeting epidermal growth factor receptor.
    Liu X; Li G
    Int J Clin Exp Pathol; 2015; 8(9):10605-14. PubMed ID: 26617770
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LncRNA LINC00319 accelerates ovarian cancer progression through miR-423-5p/NACC1 pathway.
    Du W; Feng Z; Sun Q
    Biochem Biophys Res Commun; 2018 Dec; 507(1-4):198-202. PubMed ID: 30442370
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ginsenoside 20(S)-Rg3 Prevents PKM2-Targeting miR-324-5p from H19 Sponging to Antagonize the Warburg Effect in Ovarian Cancer Cells.
    Zheng X; Zhou Y; Chen W; Chen L; Lu J; He F; Li X; Zhao L
    Cell Physiol Biochem; 2018; 51(3):1340-1353. PubMed ID: 30481782
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long non-coding RNA AGAP2-AS1, functioning as a competitive endogenous RNA, upregulates ANXA11 expression by sponging miR-16-5p and promotes proliferation and metastasis in hepatocellular carcinoma.
    Liu Z; Wang Y; Wang L; Yao B; Sun L; Liu R; Chen T; Niu Y; Tu K; Liu Q
    J Exp Clin Cancer Res; 2019 May; 38(1):194. PubMed ID: 31088485
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.